bluebird bio, Inc. (BLUE): Price and Financial Metrics
bluebird bio, Inc. (BLUE)
Today's Latest Price: $51.71 USD
Updated Oct 30 4:00pm
Add BLUE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
BLUE Stock Summary
- BLUE's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 430.72 -- higher than 92.3% of US-listed equities with positive expected earnings growth.
- With a price/sales ratio of 14.29, bluebird bio Inc has a higher such ratio than 90.16% of stocks in our set.
- Revenue growth over the past 12 months for bluebird bio Inc comes in at 323.89%, a number that bests 97.95% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to bluebird bio Inc, a group of peers worth examining would be RARE, ZYME, APTX, CLLS, and RGNX.
- Visit BLUE's SEC page to see the company's official filings. To visit the company's web site, go to www.bluebirdbio.com.
BLUE Stock Price Chart Interactive Chart >
BLUE Price/Volume Stats
| Current price | $51.71 | 52-week high | $99.36 |
| Prev. close | $52.89 | 52-week low | $38.95 |
| Day low | $51.46 | Volume | 623,200 |
| Day high | $53.79 | Avg. volume | 1,022,043 |
| 50-day MA | $55.80 | Dividend yield | N/A |
| 200-day MA | $62.00 | Market Cap | 3.42B |
bluebird bio, Inc. (BLUE) Company Bio
Bluebird Bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and T cell-based immunotherapies. The company was founded in 1992 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...